PAIA
LLY icon

Park Avenue Institutional Advisers’s Eli Lilly LLY Stock Holding History

Park Avenue Institutional Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,138
Closed -$483K – 240
2016
Q2 		$483K Sell
6,138
-10
-0.2% -$753 0.41% 53
2016
Q1 		$443K Sell
6,148
-173
-3% -$13.1K 0.38% 60
2015
Q4 		$533K Sell
6,321
-168
-3% -$13.9K 0.46% 50
2015
Q3 		$543K Sell
6,489
-105
-2% -$8.86K 0.48% 51
2015
Q2 		$551K Buy
+6,594
New +$502K 0.44% 54

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Park Avenue Institutional Advisers's LLY Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 6,138 shares — an estimated $483K sold.

Park Avenue Institutional Advisers first reported a position in LLY in Q2 2015 and held it in 5 quarters. The position peaked at $551K in Q2 2015. 1,176 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 6,138 Eli Lilly shares in Q3 2016, an estimated $483K.
  • Park Avenue Institutional Advisers first reported a position in Eli Lilly in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Eli Lilly position peaked at $551K in Q2 2015.
  • 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.